BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021

MAINZ, Germany, September 17, 2020 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX,“BioNTech” or“the Company”) today announced the signing of a share purchase agreement with Novartis AG, Basel /...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials